Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023
Published on April 27, 2023
New York, NY — April 27, 2023 — Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the first quarter ended March 31, 2023, on Thursday, May 4, 2023 after the close of the US market.
The announcement will be followed by an investor conference call and webcast on Friday, May 5, 2023 at 8:00 am ET / 2:00 pm CET. The call will include the Company’s first quarter results and an update on business activities. Details for the call are as follows:
|
Dial-in Information: |
|
|
Domestic: |
1-877-451-6152 |
|
International: |
1-201-389-0879 |
|
Conference ID: |
13737755 |
|
https://viavid.webcasts.com/starthere.jsp?ei=1608110&tp_key=92e9a57eb8 |
|